The 3D Printing Medical Devices market is projected to reach USD 5.1 billion by 2026 from USD 2.4 billion in 2021, at a CAGR of 16.3% during the forecast period. Growth of the market is mainly attributed to technological advancements; growing public and private investments and funding are driving the global 3D Printing Medical Devices market. However, complex regulatory frameworks that delay the approval of new 3D Printing Medical Devices is expected to challenge market growth to a certain extent.

“In terms of component, software & services segment to register significant growth during the forecast period.”
Based on the component, the 3D printing medical devices market is segmented equipment, materials, and software & services. Materials include plastics and biocompatible resins, polymers, metals and metal alloys, ceramics, wax, and other biomaterials. 3D printing medical device vendors are gaining significant profits from services when compared to the sales of printers and materials. In order to sustain in this highly competitive market, several vendors offer pay-as-you-go subscription services. Thus rising number of 3D printing service provider have led to the growth of Software and services segment.

“In terms application, customizable prosthetics and implants segment to register significant growth during the forecast period.”
Based on the application, the 3D Printing Medical Devices market is segmented into surgical guides, surgical instruments, standard prosthetics and implants, custom prosthetics and implants, tissue-engineered products, hearing aids, wearable medical devices/implantable medical devices, and other medical devices. The customizable prosthetics and implants segment accounted for a larger share in the market in 2020. The use of 3D printing in CMF implants is increasing in the medical and dental fields. Using this technology, bioresorbable and small plates and screws are fixed, which help maintain the 3D shape of the bone in the craniofacial skeleton. These implants can be manufactured quickly and cost-effectively, and are sterilizable.

“Laser beam melting (LBM) segment is expected to account for the largest share of the 3D Printing Medical Devices market, by the architecture” `
On the basis of technology, the 3D Printing Medical Devices market has been segmented into electron beam melting (EBM), laser beam melting (LBM), photopolymerization, droplet deposition or extrusion-based technologies, three-dimensional printing (3DP) or adhesion bonding, and other technologies. The LBM market is further segmented into direct metal laser sintering (DMLS), selective laser melting (SLM), selective laser sintering (SLS), and LaserCUSING. LBM is the most commonly used technology for the manufacture of metal and plastic parts, such as small-sized prosthetics or implants, surgical instruments, and porous scaffolds in tissue engineering. It is the best-suited technology for the production of small parts, such as dental copings and hybrid parts of machines for minimally invasive surgery, due to its high accuracy. The growth of this segment is attributed to suitability for a wide range of materials available for 3D printing, and it does not require post-processing of materials

“Asia Pacific market is expected to grow at the highest CAGR during the forecast period.”
The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period majorly due to growth of 3D printing service providers and favourable investments scenario and evolving healthcare infrastructure in China, Japan, and India

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
  • By Designation: C-level–10%, Director-level–14%, and Others–76%
  • By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%


Some of the prominent players in the 3D Printing Medical Devices market include Stratasys Ltd. (US & Israel), 3D Systems Corporation (US), GE Additive (US), Materialise NV (Belgium), Renishaw plc (UK), SLM Solutions Group AG (Germany), Desktop Metal, Inc. (US), Prodways Group (France), Carbon, Inc. (US), CELLINK (Sweden), Organovo Holdings, Inc. (US), EOS (Electro Optical Systems) GmbH (Germany), Biomedical Modeling, Inc. (US), Formlabs, Inc. (US), 3T Additive Manufacturing Ltd. (UK), DENTSPLY Sirona, Inc. (US), DWS Systems SRL (Italy), Roland DG (Japan), HP, Inc. (US), and regenHU (Switzerland) among others.

Research Coverage
This report studies the 3D Printing Medical Devices market based on component, application, technology, end user and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons To Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the 3D Printing Medical Devices market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the 3D Printing Medical Devices market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the 3D Printing Medical Devices market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.